Robert Vince (scientist)

From WikiMD's Food, Medicine & Wellness Encyclopedia

Robert Vince is an American chemist and inventor, best known for his work in the field of pharmacology. He is the director of the Center for Drug Design at the University of Minnesota and has made significant contributions to the development of drugs used in the treatment of HIV and cancer.

Early Life and Education[edit | edit source]

Robert Vince was born in New York City. He received his Bachelor of Science degree in Chemistry from St. John's University, New York, and his Ph.D. in Medicinal Chemistry from the University of Buffalo, New York.

Career[edit | edit source]

Vince began his career as a research scientist at the University of Minnesota in 1967. In 2002, he founded the Center for Drug Design at the University of Minnesota, where he currently serves as the director. His research focuses on the design and synthesis of new drugs for the treatment of various diseases, including HIV and cancer.

Contributions to Pharmacology[edit | edit source]

Vince is best known for his development of the carbovir molecule, which led to the creation of the anti-HIV drug abacavir. He also developed a new class of drugs known as vinca alkaloids, which are used in the treatment of cancer. His work has resulted in over 30 patents and numerous publications in the field of medicinal chemistry.

Awards and Recognition[edit | edit source]

Vince has received numerous awards for his contributions to the field of pharmacology, including the American Chemical Society's Medicinal Chemistry Award and the University of Minnesota's Outstanding Achievement Award. He was also inducted into the National Inventors Hall of Fame in 2014 for his work on the development of anti-HIV drugs.

See Also[edit | edit source]

References[edit | edit source]


Wiki.png

Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes

Search WikiMD


Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD

WikiMD is not a substitute for professional medical advice. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.

Contributors: Prab R. Tumpati, MD